title: Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM).
abstract: We present the main results of the first population-based cancers survival study gathering all French registry data. Survival data on 205,562 cancer cases diagnosed between 01/01/1989 and 31/12/1997 were analysed. Relative survival was estimated using an excess rate model. The evolution of the excess mortality rate over the follow-up period was graphed. The analysis emphasised the effect of age at diagnosis and its variation with time after diagnosis. For breast and prostate cancers, the age-standardised five-year relative survivals were 84% and 77%, respectively. The corresponding results in men and women were 56% versus 58% for colorectal cancer and 12% versus 16% for lung cancer. For some cancer sites, the excess mortality rate decreased to low values by five years after diagnosis. For most cancer sites, age at diagnosis was a negative prognostic factor but this effect was often limited to the first year after diagnosis.
authors.affiliation: Hospices Civils de Lyon, Service de Biostatistique, Lyon, F-69003, France. nadine.bossard@chu-lyon.fr
authors.forename: N
authors.initials: N
authors.lastname: Bossard
authors.forename: M
authors.initials: M
authors.lastname: Velten
authors.forename: L
authors.initials: L
authors.lastname: Remontet
authors.forename: A
authors.initials: A
authors.lastname: Belot
authors.forename: N
authors.initials: N
authors.lastname: Maarouf
authors.forename: A M
authors.initials: AM
authors.lastname: Bouvier
authors.forename: A V
authors.initials: AV
authors.lastname: Guizard
authors.forename: B
authors.initials: B
authors.lastname: Tretarre
authors.forename: G
authors.initials: G
authors.lastname: Launoy
authors.forename: M
authors.initials: M
authors.lastname: Colonna
authors.forename: A
authors.initials: A
authors.lastname: Danzon
authors.forename: F
authors.initials: F
authors.lastname: Molinie
authors.forename: X
authors.initials: X
authors.lastname: Troussard
authors.forename: N
authors.initials: N
authors.lastname: Bourdon-Raverdy
authors.forename: P M
authors.initials: PM
authors.lastname: Carli
authors.forename: A
authors.initials: A
authors.lastname: Jaffré
authors.forename: C
authors.initials: C
authors.lastname: Bessaguet
authors.forename: E
authors.initials: E
authors.lastname: Sauleau
authors.forename: C
authors.initials: C
authors.lastname: Schvartz
authors.forename: P
authors.initials: P
authors.lastname: Arveux
authors.forename: M
authors.initials: M
authors.lastname: Maynadié
authors.forename: P
authors.initials: P
authors.lastname: Grosclaude
authors.forename: J
authors.initials: J
authors.lastname: Estève
authors.forename: J
authors.initials: J
authors.lastname: Faivre
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D004812:Epidemiologic Methods; D005260:Female; D005602:France / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000401:mortality*; D012042:Registries / Q000706:statistics & numerical data